Research Report on pharmaceutical R & D outsourcing service industry - market status analysis and development prospect forecast

The competitive situation of enterprises in the pharmaceutical R & D outsourcing service market

      The major international market participants involved in the report are Laboratory Corporation of America Holdings (Covance)、IQVIA、Syneos Health、Paraxel International Corporation、PRA Health Sciences、Pharmaceutical Product Development (PPD)、Charles River Laboratories International Inc (CRL)、ICON Public Limited Corporation、Wuxi Apptec、Medpace Holdings, Inc etc. . The market share of these participants 、 income 、 Company profile and SWOT The analysis is included in the pharmaceutical R & D Outsourcing Service Market Research Report .

Product classification ：

clinical research

Clinical trials

Application field ：

A large company

A small company

【 Publication date 】2022-02

【 Publisher 】 Hunan beizhesi Information Consulting Co., Ltd

Reporting guidelines （ There are fifteen chapters ）： 

Chapter one ： Overview of the development of pharmaceutical R & D outsourcing service market 、 development history 、 Analysis of the size and growth rate of the Chinese market and its segments . 

Chapter two ：PEST analysis 、 Current situation of market competition at home and abroad 、 Problems and Countermeasures in the market and COVID-19 Analysis of the impact on the industry . 

The third chapter ： Analysis of upstream and downstream industrial chain of pharmaceutical R & D outsourcing service industry . 

Chapter four ： Analysis of subdivision types of pharmaceutical R & D outsourcing services （ Development trend 、 The product type 、 Competition pattern 、 And market size analysis ）. 

The fifth chapter ： End user analysis of pharmaceutical R & D outsourcing service market （ Downstream clients 、 Competition pattern 、 market potential 、 And market size analysis ）. 

Chapter six ： The output of pharmaceutical R & D outsourcing services in major regions of China 、 output value 、 sales 、 And sales value analysis . 

Chapters 7 to 13 ： North China in turn 、 Central China 、 south China 、 East China 、 The northeast 、 southwest 、 The main types of pharmaceutical R & D outsourcing services in Northwest China （ yield 、 Share of production ） And the end-user landscape （ sales 、 Sales share ） analysis . 

Chapter 14 ： This paper introduces the development status of leading enterprises , Cover company profile 、 Latest development 、 Market performance （ income 、 Price 、 Profit analysis ）、 And the introduction of products and services . 

Chapter 15 ： Research conclusion 、 Development strategy 、 Suggestions on investment direction and mode . 

Catalog

Chapter one 2016-2026 Overview of China's pharmaceutical R & D outsourcing service industry in

1.1 Overview of the development of China's pharmaceutical R & D outsourcing service industry

1.2 The development history of China's pharmaceutical R & D outsourcing service industry

1.3 2016-2026 In, the market scale of China's pharmaceutical R & D outsourcing service industry

1.4 Market analysis of pharmaceutical R & D outsourcing service segmentation

1.4.1 2016-2026 The size and growth rate of China's clinical research market in

1.4.2 2016-2026 The market size and growth rate of clinical trials in China

1.5 Analysis of the market scale of pharmaceutical R & D outsourcing services in different application fields

1.5.1 2016-2026 Market size and growth rate of China's large companies in

1.5.2 2016-2026 Market size and growth rate of small companies in China

1.6 Analysis of the market scale of pharmaceutical R & D outsourcing services in various regions of China

1.6.1 2016-2026 The scale and growth rate of the R & D outsourcing service market of Huabei pharmaceutical

1.6.2 2016-2026 The scale and growth rate of Nianhua TCM R & D outsourcing service market

1.6.3 2016-2026 The scale and growth rate of South China Pharmaceutical R & D outsourcing service market in

1.6.4 2016-2026 Market scale and growth rate of R & D outsourcing services of nianhuadong pharmaceutical

1.6.5 2016-2026 The scale and growth rate of Northeast Pharmaceutical R & D outsourcing service market in

1.6.6 2016-2026 The scale and growth rate of Southwest Pharmaceutical R & D outsourcing service market in

1.6.7 2016-2026 The scale and growth rate of Northwest pharmaceutical R & D outsourcing service market in

Chapter two The development environment of China's pharmaceutical R & D outsourcing service industry

2.1 Industry development environment analysis

2.1.1 Industry technology change analysis

2.1.2 Analysis of industrial organization innovation

2.1.3 Analysis of changes in social habits

2.1.4 Analysis of government policy changes

2.1.5 Impact of economic globalization

2.2 Analysis of industry competition at home and abroad

2.2.1 2020 Comparative analysis of the current situation and competition of pharmaceutical R & D outsourcing service market at home and abroad in

2.2.2 2020 Current situation and competitive analysis of China's pharmaceutical R & D outsourcing service market in

2.2.3 2020 Analysis on the market concentration of pharmaceutical R & D outsourcing services in China in

2.3 Problems and Countermeasures in the development of Chinese pharmaceutical R & D outsourcing service industry

2.3.1 Industry development constraints

2.3.2 Industry development considerations

2.3.3 Industry development measures and suggestions

2.3.4 Development strategy of small and medium-sized enterprises

2.4 COVID-19 Impact and Analysis on pharmaceutical R & D outsourcing service industry

The third chapter Analysis of industrial chain of pharmaceutical R & D outsourcing service industry

3.1 Pharmaceutical R & D outsourcing service industry chain

3.2 Analysis of upstream industries of pharmaceutical R & D outsourcing services

3.2.1 Development status of upstream industry

3.2.2 Upstream industry development forecast

3.2.3 Analysis of the impact of upstream industries on the pharmaceutical R & D outsourcing service industry

3.3 Analysis of downstream industries of pharmaceutical R & D outsourcing services

3.3.1 Development status of downstream industries

3.3.2 Downstream industry development forecast

3.3.3 Analysis of the impact of downstream industries on the pharmaceutical R & D outsourcing service industry

Chapter four Pharmaceutical R & D outsourcing service segment type market

4.1 Subdivision type and development trend

4.2 Commercial product types of major suppliers

4.3 Analysis of the competition pattern of the main subdivision types

4.4 Analysis of the market size of the main segmentation types of the pharmaceutical R & D outsourcing service industry

4.4.1 Clinical research market size and growth rate

4.4.2 Market size and growth rate of clinical trials

The fifth chapter End user segmentation of pharmaceutical R & D outsourcing service market

5.1 End user downstream client analysis

5.2 Competitive landscape analysis of major end users

5.3 Market potential analysis of major end users

5.4 Analysis of the market size of the main end users of pharmaceutical R & D outsourcing services

5.4.1 The market size and growth rate of pharmaceutical R & D outsourcing services in the field of large companies

5.4.2 The market size and growth rate of pharmaceutical R & D outsourcing services in the field of small companies

Chapter six Analysis of pharmaceutical R & D outsourcing service market in major regions of China

6.1 Analysis of output and output value of pharmaceutical R & D outsourcing services in major regions of China

6.2 Analysis of sales volume and sales value of pharmaceutical R & D outsourcing services in major regions of China

Chapter vii. Analysis of pharmaceutical R & D outsourcing service market in North China

7.1 Analysis of the main types and patterns of pharmaceutical R & D outsourcing services in North China

7.2 Analysis on the pattern of major end users of pharmaceutical R & D outsourcing services in North China

Chapter viii. Analysis of pharmaceutical R & D outsourcing service market in Central China

8.1 Analysis of the main types and patterns of pharmaceutical R & D outsourcing services in Central China

8.2 Analysis on the pattern of main end users of pharmaceutical R & D outsourcing services in Central China

Chapter nine Analysis of pharmaceutical R & D outsourcing service market in South China

9.1 Analysis of the main types and patterns of pharmaceutical R & D outsourcing services in South China

9.2 Analysis on the pattern of main end users of pharmaceutical R & D outsourcing services in South China

Chapter ten Analysis of pharmaceutical R & D outsourcing service market in East China

10.1 Analysis of the main types and patterns of pharmaceutical R & D outsourcing services in East China

10.2 Analysis on the pattern of main end users of pharmaceutical R & D outsourcing services in East China

Chapter 11 Analysis of pharmaceutical R & D outsourcing service market in Northeast China

11.1 Analysis of the main types and patterns of pharmaceutical R & D outsourcing services in Northeast China

11.2 Analysis on the pattern of main end users of pharmaceutical R & D outsourcing services in Northeast China

Chapter 12 Analysis of pharmaceutical R & D outsourcing service market in Southwest China

12.1 Analysis of the main types and patterns of pharmaceutical R & D outsourcing services in Southwest China

12.2 Analysis on the pattern of main end users of pharmaceutical R & D outsourcing services in Southwest China

Chapter 13 Analysis of pharmaceutical R & D outsourcing service market in Northwest China

13.1 Analysis of the main types and patterns of pharmaceutical R & D outsourcing services in Northwest China

13.2 Analysis on the pattern of main end users of pharmaceutical R & D outsourcing services in Northwest China

Chapter 14 Major enterprises

14.1 Laboratory Corporation of America Holdings (Covance)

14.1.1 Laboratory Corporation of America Holdings (Covance)- Company profile and latest developments

14.1.2 Market performance

14.1.3 Product service and introduction

14.2 IQVIA

14.2.1 IQVIA- Company profile and latest developments

14.2.2 Market performance

14.2.3 Product service and introduction

14.3 Syneos Health

14.3.1 Syneos Health- Company profile and latest developments

14.3.2 Market performance

14.3.3 Product service and introduction

14.4 Paraxel International Corporation

14.4.1 Paraxel International Corporation- Company profile and latest developments

14.4.2 Market performance

14.4.3 Product service and introduction

14.5 PRA Health Sciences

14.5.1 PRA Health Sciences- Company profile and latest developments

14.5.2 Market performance

14.5.3 Product service and introduction

14.6 Pharmaceutical Product Development (PPD)

14.6.1 Pharmaceutical Product Development (PPD)- Company profile and latest developments

14.6.2 Market performance

14.6.3 Product service and introduction

14.7 Charles River Laboratories International Inc (CRL)

14.7.1 Charles River Laboratories International Inc (CRL)- Company profile and latest developments

14.7.2 Market performance

14.7.3 Product service and introduction

14.8 ICON Public Limited Corporation

14.8.1 ICON Public Limited Corporation- Company profile and latest developments

14.8.2 Market performance

14.8.3 Product service and introduction

14.9 Wuxi Apptec

14.9.1 Wuxi Apptec- Company profile and latest developments

14.9.2 Market performance

14.9.3 Product service and introduction

14.10 Medpace Holdings, Inc

14.10.1 Medpace Holdings, Inc- Company profile and latest developments

14.10.2 Market performance

14.10.3 Product service and introduction

Chapter 15 Research conclusions and investment suggestions

15.1 Research conclusion of pharmaceutical R & D outsourcing service industry

15.2 Investment suggestions for pharmaceutical R & D outsourcing service industry

15.2.1 Suggestions on industry development strategy

15.2.2 Suggestions on industry investment direction

15.2.3 Suggestions on industry investment mode

Table of figures

chart 2016-2026 In, the market scale of China's pharmaceutical R & D outsourcing service industry

chart 2016-2026 The size and growth rate of China's clinical research market in

chart 2016-2026 The market size and growth rate of clinical trials in China

chart 2016-2026 The market size and growth rate of Chinese pharmaceutical R & D outsourcing services in the field of large companies in

chart 2016-2026 The market size and growth rate of Chinese pharmaceutical R & D outsourcing services in the field of small companies in

chart 2016-2026 The scale and growth rate of the R & D outsourcing service market of Huabei pharmaceutical

chart 2016-2026 The scale and growth rate of Nianhua TCM R & D outsourcing service market

chart 2016-2026 The scale and growth rate of South China Pharmaceutical R & D outsourcing service market in

chart 2016-2026 Market scale and growth rate of R & D outsourcing services of nianhuadong pharmaceutical

chart 2016-2026 The scale and growth rate of Northeast Pharmaceutical R & D outsourcing service market in

chart 2016-2026 The scale and growth rate of Southwest Pharmaceutical R & D outsourcing service market in

chart 2016-2026 The scale and growth rate of Northwest pharmaceutical R & D outsourcing service market in

chart Pharmaceutical R & D outsourcing service industry chain

surface 2020 Commercial product types of major suppliers in

chart 2016 Market share distribution of major segments in

chart 2020 Market share distribution of major segments in

chart 2016-2021 The size and growth rate of the clinical research market in

chart 2016-2021 Market size and growth rate of clinical trials in

chart 2016 Market share distribution of major end users in

chart 2020 Market share distribution of major end users in

chart 2016-2021 In, the market size and growth rate of pharmaceutical R & D outsourcing services in the field of large companies

chart 2016-2021 In, the market size and growth rate of pharmaceutical R & D outsourcing services in the field of small companies

surface 2016-2021 In, the output of pharmaceutical R & D outsourcing services in major regions of China

surface 2016-2021 In, the output share of pharmaceutical R & D outsourcing services in major regions of China

chart 2016-2021 In, the output share of pharmaceutical R & D outsourcing services in major regions of China

surface 2016-2021 In, the output value of pharmaceutical R & D outsourcing services in major regions of China

surface 2016-2021 Share of output value of pharmaceutical R & D outsourcing services in major regions in China

chart 2016-2021 Share of output value of pharmaceutical R & D outsourcing services in major regions in China

surface 2016-2021 Sales of pharmaceutical R & D outsourcing services in major regions of China

surface 2016-2021 Sales share of pharmaceutical R & D outsourcing services in major regions of China in

chart 2016-2021 Sales share of pharmaceutical R & D outsourcing services in major regions of China in

surface 2016-2021 Sales value of pharmaceutical R & D outsourcing services in major regions of China in

surface 2016-2021 Share of sales value of pharmaceutical R & D outsourcing services in major regions in China

chart 2016-2021 Share of sales value of pharmaceutical R & D outsourcing services in major regions in China

surface 2016-2021 In, the output of the main types of pharmaceutical R & D outsourcing services in northern China

surface 2016-2021 Output share of the main types of pharmaceutical R & D outsourcing services in northern China

chart 2016-2021 Output share of the main types of pharmaceutical R & D outsourcing services in northern China

surface 2016-2021 In, the sales volume of pharmaceutical R & D outsourcing services in North China was mainly for end users

surface 2016-2021 Sales volume share of major end users of pharmaceutical R & D outsourcing services in northern China

chart 2016-2021 Sales volume share of major end users of pharmaceutical R & D outsourcing services in northern China

surface 2016-2021 The output of the main types of pharmaceutical R & D outsourcing services in Central China

surface 2016-2021 Output share of major types of pharmaceutical R & D outsourcing services in Central China

chart 2016-2021 Output share of major types of pharmaceutical R & D outsourcing services in Central China

surface 2016-2021 The main end-user sales of pharmaceutical R & D outsourcing services in Central China

surface 2016-2021 Sales share of major end users of pharmaceutical R & D outsourcing services in Central China

chart 2016-2021 Sales share of major end users of pharmaceutical R & D outsourcing services in Central China

surface 2016-2021 In, the output of major types of pharmaceutical R & D outsourcing services in South China

surface 2016-2021 Output share of major types of pharmaceutical R & D outsourcing services in South China in

chart 2016-2021 Output share of major types of pharmaceutical R & D outsourcing services in South China in

surface 2016-2021 Sales volume of major end users of pharmaceutical R & D outsourcing services in South China in

surface 2016-2021 Sales volume share of major end users of pharmaceutical R & D outsourcing services in South China in

chart 2016-2021 Sales volume share of major end users of pharmaceutical R & D outsourcing services in South China in

surface 2016-2021 The output of the main types of pharmaceutical R & D outsourcing services in East China

surface 2016-2021 Output share of main types of pharmaceutical R & D outsourcing services in East China

chart 2016-2021 Output share of main types of pharmaceutical R & D outsourcing services in East China

surface 2016-2021 The main end-user sales of pharmaceutical R & D outsourcing services in East China

surface 2016-2021 Sales share of major end users of pharmaceutical R & D outsourcing services in East China

chart 2016-2021 Sales share of major end users of pharmaceutical R & D outsourcing services in East China

surface 2016-2021 In, the output of the main types of pharmaceutical R & D outsourcing services in Northeast China

surface 2016-2021 In, the output share of the main types of pharmaceutical R & D outsourcing services in Northeast China

chart 2016-2021 In, the output share of the main types of pharmaceutical R & D outsourcing services in Northeast China

surface 2016-2021 In, the sales volume of major end users of pharmaceutical R & D outsourcing services in Northeast China

surface 2016-2021 The sales volume share of major end users of pharmaceutical R & D outsourcing services in Northeast China in

chart 2016-2021 The sales volume share of major end users of pharmaceutical R & D outsourcing services in Northeast China in

surface 2016-2021 In, the output of the main types of pharmaceutical R & D outsourcing services in Southwest China

surface 2016-2021 Output share of major types of pharmaceutical R & D outsourcing services in Southwest China in

chart 2016-2021 Output share of major types of pharmaceutical R & D outsourcing services in Southwest China in

surface 2016-2021 In, the sales volume of major end users of pharmaceutical R & D outsourcing services in Southwest China

surface 2016-2021 Sales share of major end users of pharmaceutical R & D outsourcing services in Southwest China in

chart 2016-2021 Sales share of major end users of pharmaceutical R & D outsourcing services in Southwest China in

surface 2016-2021 In, the output of major types of pharmaceutical R & D outsourcing services in Northwest China

surface 2016-2021 Output share of major types of pharmaceutical R & D outsourcing services in Northwest China in

chart 2016-2021 Output share of major types of pharmaceutical R & D outsourcing services in Northwest China in

surface 2016-2021 Sales volume of major end users of pharmaceutical R & D outsourcing services in Northwest China in

surface 2016-2021 Sales share of major end users of pharmaceutical R & D outsourcing services in Northwest China in

chart 2016-2021 Sales share of major end users of pharmaceutical R & D outsourcing services in Northwest China in

surface Laboratory Corporation of America Holdings (Covance)- Company profile and latest developments

surface 2016-2021 year Laboratory Corporation of America Holdings (Covance) Revenue from pharmaceutical R & D outsourcing services 、 Price 、 Profit analysis

surface IQVIA- Company profile and latest developments

surface 2016-2021 year IQVIA Revenue from pharmaceutical R & D outsourcing services 、 Price 、 Profit analysis

surface Syneos Health- Company profile and latest developments

surface 2016-2021 year Syneos Health Revenue from pharmaceutical R & D outsourcing services 、 Price 、 Profit analysis

surface Paraxel International Corporation- Company profile and latest developments

surface 2016-2021 year Paraxel International Corporation Revenue from pharmaceutical R & D outsourcing services 、 Price 、 Profit analysis

surface PRA Health Sciences- Company profile and latest developments

surface 2016-2021 year PRA Health Sciences Revenue from pharmaceutical R & D outsourcing services 、 Price 、 Profit analysis

surface Pharmaceutical Product Development (PPD)- Company profile and latest developments

surface 2016-2021 year Pharmaceutical Product Development (PPD) Revenue from pharmaceutical R & D outsourcing services 、 Price 、 Profit analysis

surface Charles River Laboratories International Inc (CRL)- Company profile and latest developments

surface 2016-2021 year Charles River Laboratories International Inc (CRL) Revenue from pharmaceutical R & D outsourcing services 、 Price 、 Profit analysis

surface ICON Public Limited Corporation- Company profile and latest developments

surface 2016-2021 year ICON Public Limited Corporation Revenue from pharmaceutical R & D outsourcing services 、 Price 、 Profit analysis

surface Wuxi Apptec- Company profile and latest developments

surface 2016-2021 year Wuxi Apptec Revenue from pharmaceutical R & D outsourcing services 、 Price 、 Profit analysis

surface Medpace Holdings, Inc- Company profile and latest developments

surface 2016-2021 year Medpace Holdings, Inc Revenue from pharmaceutical R & D outsourcing services 、 Price 、 Profit analysis